TCF/LEF StemBright™ Luciferase iPS Cell Pool (Wnt Pathway)

Catalog #
78515
$5,950 *
Size: 1 vial
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The TCF/LEF (T-cell factor/lymphoid enhancing factor) StemBright™ Luciferase Cells contain a firefly luciferase gene under the control of TCF/LEF responsive elements, stably integrated into induced Pluripotent Stem (iPS) cells. TCF/LEF transcription factors are downstream of the Wnt signaling pathway. This cell pool is validated for its response to GSK3β inhibitor CHIR-99021, which activates the Wnt signaling pathway in human pluripotent stem cells.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Synonyms
iPSC
Product Info
Storage and Usage
Citations
Host Cell Line
Non-Disease Human iPS Cell Line (iXCells 30HU-002)
Supplied As
Each vial contains 2 x 106 cells in 1 ml of iPS cell freezing medium
Materials Required But Not Supplied

Media Required for Cell Culture

Name Ordering Information
mTeSR™ Plus Stem Cell Technologies #100-0276
Matrigel™  Corning #354230
DMEM/F12 Thermo Fisher #11330032
Thiazovivin BPS Bioscience #78506
RelesR Stem Cell Technologies #05872
Accutase Thermo Fisher #A1110501


Materials Used in the Cellular Assay

Name Ordering Information
CHIR-99021 BPS Bioscience #27614
ONE-Step™ Luciferase Assay System BPS Bioscience #60690
Luminometer  
Mycoplasma Testing

The cell line has been screened to confirm the absence of Mycoplasma species.

Background

The Wnt signaling pathway is a well described regulator of organism development and cell fate specification. Cellular pluripotency and differentiation of multiple lineages, including cardiomyocytes and neurons are modulated by this pathway. There are 19 Wnt ligands and 10 Frizzled receptors, which stimulate canonical as well as non-canonical Wnt pathways. In the canonical pathway, cell activation by a Wnt ligand leads to the stabilization and nuclear translocation of β-catenin and subsequent activation of TCF/LEF transcription factor. The Wnt signaling pathway has recently been shown to play a role in cell cycle reentry and proliferation of iPS-derived cardiomyocytes. It is a therapeutic target in the treatment of neuropsychiatric disorders.